glp 1 drugs safe GLP-1 Medications: Everything You Need to Know Thinking of GLP-1s as a
Description
It has the longer safety record with cardiovascular outcomes data now extending beyond 5 years and is widely available
Newswise Researchers at Washington University School of Medicine in St
The phase 3 TRIUMPH-4 trial confirmed and extended these findings
A recent randomized study just published in the Lancet in 2025 evaluated 194 folks randomly assigned to Exenatide (n=97) or placebo (n=97)
Available from: 11
Zealand and Boehringer Ingelheim have survodutide in Phase 3 trials and is included in the GLP1 Pipeline Update
